Disease relevance of gallanylidynearsane

• These changes were associated with GaAs and InAs proteinuria patterns as monitored by two-dimensional gel electrophoresis and silver staining [1].
• BACKGROUND AND OBJECTIVES: A prospective, double-blind, randomized, and controlled trial was conducted in patients with knee osteoarthritis (OA) to evaluate the efficacy of infrared low-power Gallium-Arsenide (Ga-As) laser therapy (LPLT) and compared two different laser therapy regimes [2].
• BACKGROUND AND OBJECTIVES: The aim of this study was to determine whether low power laser therapy (Gallium-Arsenide) is useful or not for the therapy of chronic low back pain (LBP) [3].
• BACKGROUND AND OBJECTIVES: A prospective, double-blind, randomized, and controlled trial was conducted in patients with chronic myofascial pain syndrome (MPS) in the neck to evaluate the effects of infrared low level 904 nm Gallium-Arsenide (Ga-As) laser therapy (LLLT) on clinical and quality of life (QoL) [4].
• OBJECTIVE: The objective of this study is to investigate the effect of low-power gallium-arsenide laser treatment on the patients with shoulder pain [5].

Psychiatry related information on gallanylidynearsane

• Irradiation of a gallium arsenide (GaAs) crystal using picosecond laser pulses shifts the Bragg angle through the lattice expansion with a response time of a few hundred picoseconds [6].

High impact information on gallanylidynearsane

• Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages [7].
• Gallium arsenide impacted different intracellular compartments in these macrophages, perhaps contributing to systemic immunotoxicity and local inflammation caused by exposure [8].
• Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation [9].
• Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55) [10].
• Acute electrophysiologic effect of pulsed gallium-arsenide low energy laser irradiation on configuration of compound nerve action potential and nerve excitability [11].

Biological context of gallanylidynearsane

• Cultured human lymphocytes were subjected to irradiation with a gallium-arsenide laser at energy fluence varying from 2.17 to 651 mJ/cm2, and the cell proliferation was assessed by [3H]thymidine incorporation [12].
• Furthermore, two low-energy lasers, helium-neon (He-Ne) and gallium-arsenide (Ga-As), were shown to stimulate collagen production in human skin fibroblast cultures, suggesting that these lasers could be used for enhancement of wound healing processes [13].

Anatomical context of gallanylidynearsane

• Laser modulation of human immune system: inhibition of lymphocyte proliferation by a gallium-arsenide laser at low energy [12].
• Gallium arsenide (GaAs) suppresses numerous immunologic functions of leukocytes at distal locations from the exposure site [14].
• Gallium arsenide (GaAs) has been shown previously to suppress the in vivo antibody-forming cell (AFC) response to sheep erythrocytes (SRBC) when administered intratracheally at concentrations between 50 and 200 mg/kg [15].
• BACKGROUND AND OBJECTIVE: In this study, the effect of low energy Gallium arsenide (GaAs) laser irradiation on the compound action potential of frog gastrocnemius muscle were investigated [16].
• Gallium arsenide augments antigen processing by peritoneal macrophages for CD4+ helper T cell stimulation [14].

Associations of gallanylidynearsane with other chemical compounds

• Previous studies have demonstrated that the intratracheal or subcutaneous administration of GaAs and InAs particles to hamsters produces the induction of the major stress protein gene families in renal proximal tubule cells [1].
• The effect of low power Helium-Neon (He-Ne) and Gallium-Arsenide (Ga-As) laser on the slowly adapting crustacean stretch receptor was studied [17].

Gene context of gallanylidynearsane

• Gallium arsenide is used as the TEM specimen [18].
• Gallium arsenide (GaAs) inhibited, dose dependently, delta-aminolevulinic acid dehydratase (ALAD) activity in blood (as observed on days 1, 7 and 15), liver and brain (on day 15) after a single oral treatment [19].

Analytical, diagnostic and therapeutic context of gallanylidynearsane

• Gallium arsenide, a semiconductor utilized in the electronics industry, causes immunosuppression in animals [8].
• The present studies examined whether these effects were associated with the development of compound-specific proteinuria after 10 or 30 days following subcutaneous injection of GaAs or InAs particles in hamsters [1].

References